Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 16Colonic Neoplasms 3Colorectal Neoplasms, Hereditary Nonpolyposis 2Anus Neoplasms 2Adenomatous Polyposis Coli 2Turcot syndrome 1Rectal Neoplasms 1Polyps 1Pathologic Complete Response 1Lymphoma, Mantle-Cell 1HIV Infections 1Disease 1Digestive System Diseases 1Colon Cancer Screening 1Colitis, Ulcerative 1Benign Colorectal Neoplasm 1Anal Canal Carcinoma 1Adenoma 1

Interventions

Specimen Handling 2Nivolumab 2Educational Status 2pembrolizumab 1cabozantinib 1Standard of Care 1Practice Guidelines as Topic 1Platinum Compounds 1NX-13 1Methods 1Ipilimumab 1Interviews as Topic 1Infliximab 1Early Intervention, Educational 1Colonoscopy 1CTLA-4 Antigen 1Biopsy 1Atorvastatin 1ABX464 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Colitis, Ulcerative × Colonoscopy × 1 year × Clear all
NCT04767984 2026-01-21

Testing Atorvastatin to Lower Colon Cancer Risk in Longstanding Ulcerative Colitis

Northwestern University

Phase 2 Active not recruiting
42 enrolled
Gastrointestinal

Colitis, Ulcerative, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡